IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?

被引：24

作者：

Baeten, Dominique ^{[1
,2
]}

Adamopoulos, Iannis E. ^{[3
]}

机构：

[1] Amsterdam Univ Med Ctr, Clin Immunol & Rheumatol, Amsterdam, Netherlands

[2] UCB, Immunol Therapeut Area, Slough, Berks, England

[3] Beth Israel Med Deaconess Ctr, Dept Med, Div Rheumatol & Clin Immunol, Boston, MA USA

来源：

FRONTIERS IN IMMUNOLOGY | 2021年 / 11卷

关键词：

interleukin-23; interleukin-17; ankylosing spondylitis; axial spondyloarthritis; Th17;

D O I：

10.3389/fimmu.2020.623874

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Axial spondyloarthritis is a prevalent form of chronic arthritis which is related to psoriatic arthritis and skin psoriasis. TNF and IL-17A as well as IL-17F are key cytokines contributing to the pathobiology of this disease, as evidence by the therapeutic efficacy of inhibition of these factors. Despite the evidence that IL-23 acts as an upstream driver of Th17 cells, the T lymphocytes producing IL-17, and that IL-23 inhibition shows profound efficacy in psoriasis, blocking IL-23 failed to show any evidence of clinical efficacy in axial spondyloarthritis. In this viewpoint article, we revisit the reasons-to-believe in a role of IL-23 in the pathobiology of axial spondyloarthritis, discuss what we have learned on the pathobiology of this disease in general and on the function of the IL-23/IL-17 axis in particular, and share a handful of lessons learned that are of relevance for the translation of emerging biological insights into clinical therapeutics.

引用

页数：4

共 34 条

[21] A Macrophage Colony-Stimulating-Factor-Producing γδ T Cell Subset Prevents Malarial Parasitemic Recurrence [J].

Mamedov, Murad R. ;

Scholzen, Anja ;

Nair, Ramesh V. ;

Cumnock, Katherine ;

Kenkel, Justin A. ;

Oliveira, Jose Henrique M. ;

Trujillo, Damian L. ;

Saligrama, Naresha ;

Zhang, Yue ;

Rubelt, Florian ;

Schneider, David S. ;

Chien, Yueh-hsiu ;

Sauerwein, Robert W. ;

Davis, Mark M. .

IMMUNITY, 2018, 48 (02) :350-+

[22] The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation [J].

Manthiram, Kalpana ;

Zhou, Qing ;

Aksentijevich, Ivona ;

Kastner, Daniel L. .

NATURE IMMUNOLOGY, 2017, 18 (08) :832-842

[23] Association between the IL-1 family gene cluster and spondyloarthritis [J].

Monnet, Dominique ;

Kadi, Amir ;

Izac, Brigitte ;

Lebrun, Nicolas ;

Letourneur, Franck ;

Zinovieva, Elena ;

Said-Nahal, Roula ;

Chiocchia, Gilles ;

Breban, Maxime .

ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (06) :885-890

[24] Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS) [J].

Poddubnyy, Denis ;

Hermann, Kay-Geert A. ;

Callhoff, Johanna ;

Listing, Joachim ;

Sieper, Joachim .

ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (05) :817-823

[25] Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial [J].

Reich, Kristian ;

Armstrong, April W. ;

Langley, Richard G. ;

Flavin, Susan ;

Randazzo, Bruce ;

Li, Shu ;

Hsu, Ming-Chun ;

Branigan, Patrick ;

Blauvelt, Andrew .

LANCET, 2019, 394 (10201) :831-839

[26] Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci [J].

Reveille, John D. ;

Sims, Anne-Marie ;

Danoy, Patrick ;

Evans, David M. ;

Leo, Paul ;

Pointon, Jennifer J. ;

Jin, Rui ;

Zhou, Xiaodong ;

Bradbury, Linda A. ;

Appleton, Louise H. ;

Davis, John C. ;

Diekman, Laura ;

Doan, Tracey ;

Dowling, Alison ;

Duan, Ran ;

Duncan, Emma L. ;

Farrar, Claire ;

Hadler, Johanna ;

Harvey, David ;

Karaderi, Tugce ;

Mogg, Rebecca ;

Pomeroy, Emma ;

Pryce, Karena ;

Taylor, Jacqueline ;

Savage, Laurie ;

Deloukas, Panos ;

Kumanduri, Vasudev ;

Peltonen, Leena ;

Ring, Sue M. ;

Whittaker, Pamela ;

Glazov, Evgeny ;

Thomas, Gethin P. ;

Maksymowych, Walter P. ;

Inman, Robert D. ;

Ward, Michael M. ;

Stone, Millicent A. ;

Weisman, Michael H. ;

Wordsworth, B. Paul ;

Brown, Matthew A. .

NATURE GENETICS, 2010, 42 (02) :123-U47

[27] Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells [J].

Shah, Mittal ;

Maroof, Asher ;

Gikas, Panos ;

Mittal, Gayatri ;

Keen, Richard ;

Baeten, Dominique ;

Shaw, Stevan ;

Roberts, Scott J. .

RMD OPEN, 2020, 6 (02)

[28] IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells [J].

Sherlock, Jonathan P. ;

Joyce-Shaikh, Barbara ;

Turner, Scott P. ;

Chao, Cheng-Chi ;

Sathe, Manjiri ;

Grein, Jeff ;

Gorman, Daniel M. ;

Bowman, Edward P. ;

McClanahan, Terrill K. ;

Yearley, Jennifer H. ;

Eberl, Gerard ;

Buckley, Christopher D. ;

Kastelein, Robert A. ;

Pierce, Robert H. ;

LaFace, Drake M. ;

Cua, Daniel J. .

NATURE MEDICINE, 2012, 18 (07) :1069-+

[29] Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study [J].

Tan, AL ;

Marzo-Ortega, H ;

O'Connor, P ;

Fraser, A ;

Emery, P ;

McGonagle, D .

ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (09) :1041-1045

[30] A psychometric analysis of outcome measures in peripheral spondyloarthritis [J].

Turina, Maureen C. ;

Ramiro, Sofia ;

Baeten, Dominique L. ;

Mease, Philip ;

Paramarta, Jacqueline E. ;

Song, In-Ho ;

Pangan, Aileen L. ;

Landewe, Robert .

ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (07) :1302-1307

← 1 2 3 4 →